Stock listing

MRNA Stock Price, News, Filings & Events — Moderna, Inc.

Selected listing: MRNA · BOATS · USD · US

This page tracks Moderna, Inc.'s MRNA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MRNA:BOATS. MRNA:BOATS is the stock-level entry point for investors researching Moderna, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Moderna, Inc. is a public company traded under the ticker MRNA in the American market. The company has a market capitalization of approximately $24.53 billion. Moderna is known for its innovative work in biotechnology, particularly in the development of mRNA-based therapeutics and vaccines.

MRNA:BOATSUSDUSUpdated August 28, 2026
Moderna, Inc. logo
Ticker
MRNA:BOATS
Asset type
Stock
Market cap
$55.09B
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Moderna, Inc. MRNA:BOATS stock context

This page tracks Moderna, Inc.'s MRNA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MRNA:BOATS. MRNA:BOATS is the stock-level entry point for investors researching Moderna, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Moderna, Inc. is a public company traded under the ticker MRNA in the American market. The company has a market capitalization of approximately $24.53 billion. Moderna is known for its innovative work in biotechnology, particularly in the development of mRNA-based therapeutics and vaccines.

Latest news from Moderna, Inc.

All Moderna, Inc. news →

Moderna, Inc. earnings calls

Research Moderna, Inc.

Alternate listings